Form 8-K - Current report:
SEC Accession No. 0000950170-25-056005
Filing Date
2025-04-21
Accepted
2025-04-21 07:08:09
Documents
14
Period of Report
2025-04-18
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ivvd-20250418.htm   iXBRL 8-K 73017
2 EX-10.1 ivvd-ex10_1.htm EX-10.1 836370
3 EX-99.1 ivvd-ex99_1.htm EX-99.1 21549
4 GRAPHIC img59752938_0.jpg GRAPHIC 85687
  Complete submission text file 0000950170-25-056005.txt   1289004

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT ivvd-20250418.xsd EX-101.SCH 31867
16 EXTRACTED XBRL INSTANCE DOCUMENT ivvd-20250418_htm.xml XML 4874
Mailing Address 1601 TRAPELO ROAD SUITE 178 WALTHAM MA 02451
Business Address 1601 TRAPELO ROAD SUITE 178 WALTHAM MA 02451 (781) 819-0080
Invivyd, Inc. (Filer) CIK: 0001832038 (see all company filings)

EIN.: 851403134 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40703 | Film No.: 25851291
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)